Abiopharma

CME GROUP INC. (CME)

Symbol	CME
Name	CME GROUP INC.
Sector	FINANCE
Region	North America
Industry	Investment Bankers/Brokers/Service
Address	20 SOUTH WACKER DRIVE, CHICAGO, Illinois, 60606, United States
Telephone	+1 312 930-1000
Fax	—
Email	—
Website	https://www.cmegroup.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001156375
Description	Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CMEs acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization. Additional info from NASDAQ: Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CMEs acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

2026-07-22 11:15

(99% Positive) CME GROUP INC. (CME) Reports Q3 2026 Financial Results

2026-07-22 11:00

CME Group Inc. Reports Strong Financial Results for Q2 2026

2026-06-29 20:30

Director GEPSMAN MARTIN J 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:28

Director SHEPARD WILLIAM R 🟢 acquired 1.4K shares of CME GROUP INC. (CME) at $230.57 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:27

Director Seifu Rahael 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:25

Director Suskind Dennis 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:24

Director SIEGEL HOWARD J 🟢 acquired 1.1K shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:22

Director Mulchrone Patrick J 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:21

Director Maloney Patrick W 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003

2026-06-29 20:20

Director Lucas Deborah J 🟢 acquired 645 shares of CME GROUP INC. (CME) at $225.00 Transaction Date: Jun 25, 2026 | Filing ID: 000003